An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2016 Jun 29;10(5):594–597. doi: 10.1016/j.jcmg.2016.02.029
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease
aTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York
bDepartment of Nuclear Medicine, European University of Brittany, Brest, France
cBritish Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
dDivision of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
eCardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York
✉
REPRINT REQUESTS AND CORRESPONDENCE: Dr. Marc R. Dweck, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, P.O. Box 1234, New York, New York 10029-6574. marc.dweck@ed.ac.uk
#
Drs. Abgral and Dweck contributed equally to this work.
Issue date 2017 May.
Keywords:18F-fluorodeoxyglucose, late gadolinium enhancement, PET/MR
The assessment of both the pattern and activity of myocardial injury has important implications for the clinical management of patients with cardiovascular disease. Comprehensive evaluation of these has previously been challenging using a single imaging modality.
Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) has become well established for differentiating the patterns of injury observed in a range of conditions. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is widely used to measure inflammation activity in the vasculature and myocardium.
The advent of simultaneous PET/MR imaging now allows combination of these 2 techniques alongside cardiac function with major advantages in terms of image coregistration, interpretation, and radiation exposure. In this report, we present 3 clinical cases (Figures 1 to 3, Online Videos 1, 2, 3, and 4) where the initial etiology and activity of the disease process was unclear but resolved after addition of FDG PET/MR (Biograph mMR, Siemens, Healthineers, Erlangen, Germany) to the clinical context. A fourth case (Figure 4, Online Videos 5 and 6) highlights the potential for false positive FDG signal in the myocardium (1).
Hybrid FDG-PET/MR offers complementary information with the ability to image myocardial function, the pattern of injury, and disease activity in a single scan.
This work was supported by a National Institutes of Health/National Heart, Lung, and Blood Institute grant R01HL071021 (to Z.A.F.). Dr. Dweck is supported by the British Heart Foundation (FS/14/78/31020). Dr. Narula has received institutional equipment grants from Philips and GE Healthcare; and speaking honoraria from GE Healthcare.